| |
OS
| |
DFS
|
|---|
|
HR
|
95.0% CI
|
P
|
HR
|
95.0% CI
|
P
|
|---|
|
B symptoms
|
4.55
|
1.21–16.96
|
0.02*
|
Bulky disease
|
1.22
|
0.24-6.06
|
0.8
|
|
Bulky disease
|
0.66
|
0.2–2.18
|
0.5
|
CD68
|
0.88
|
|
IPS ≥ 3
|
3.55
|
1.95–10.521
|
0.02*
|
CD68 (score II)
|
0.83
|
0.12–5.8
|
0.85
|
|
CD163
|
0.003*
|
CD68 (score III)
|
0.36
|
0.007–19.6
|
0.62
|
|
CD163 (score II)
|
1.78
|
0.41–7.74
|
0.44
|
CD163
|
0.3
|
|
CD163 (score III)
|
9.39
|
2.19–40.22
|
0.003*
|
CD163 (score II)
|
2.0
|
0.3–13.1
|
0.47
|
| | |
CD163 (score III)
|
25.5
|
0.41–1571.7
|
0.12
|
- OS overall survival, DFS disease-free survival, HR hazard ratio, CI confidence interval, IPS International Prognostic score
